The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible In vivo regulatory mechanisms
Abstract
We have previously suggested that tumor angiogenesis in human gliomas is regulated by a paracrine mechanism involving vascular endothelial growth factor (VEGF) and flt‐I (VEGF‐receptor I). VEGF, an endothelial‐cell‐specific mitogen, is abundantly expressed in glioma cells which reside along necrotic areas, whereas fit‐I, a tyrosine‐kinase receptor for VEGF, is expressed in tumor endothelial cells, but not in endothelial cells in normal adult brain. Recently, a second tyrosine‐kinase receptor which binds VEGF with high affinity, designated KDR or flk‐I, has been described. We performed in situ hybridization for VEGF mRNA, flt‐I mRNA and KDR mRNA on serial sections of normal brain, low‐grade and high‐grade glioma specimens. We show that KDR mRNA is co‐expressed with flt‐I in vascular cells in glioblastoma but not in low‐grade glioma. Since flt‐I and KDR are not expressed in endothelial cells in the normal adult brain, the coordinate up‐regulation of 2 receptors for VEGF appears to be a critical event which controls tumor angiogenesis. Immunocytochemistry with a monoclonal anti‐VEGF antibody revealed significant amounts of VEGF protein in the same glioma cells that expressed VEGF mRNA. The largest amount of VEGF immunoreactivity, however, was detected on the vasculature of glioblastomas, the site where VEGF exerts its biological functions. These findings suggest that VEGF is produced and secreted by glioma cells and acts on tumor endothelial cells which express VEGF receptors. To further characterize VEGF‐producer cells in vivo, we investigated cellular proliferation, immunoreactivity to the p53 tumor‐suppressor gene product and epidermal‐growth‐factor‐receptor(EGFR) expression on serial sections by immunocytochemistry. VEGF‐producer cells did not show increased cellular proliferation, p53 immunoreactivity or EGFR immunoreactivity as compared with glioma cells which did not express VEGF. Our studies therefore do not demonstrate evidence for a growth advantage of VEGF‐producer cells in vivo or VEGF induction by p53 mutation or EGFR over‐expression. © 1994 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Pathology of Tumours of the Nervous System
(1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199001000-00011 · Cited by 3,472
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Self-citationVascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Self-citationMolecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Cited by
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,820
Self-citationStem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor
Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., Hjelmeland, A. B., Shi, Q., McLendon, R. E., Bigner, D. D., & Rich, J. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1010 · Cited by 1,345
Vascular endothelial growth factors and angiogenesis in eye disease
Witmer, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00043-5 · Cited by 927
Seghezzi, G., Patel, S., Ren, C. J., Gualandris, A., Pintucci, G., Robbins, E. S., Shapiro, R. L., Galloway, A. C., Rifkin, D. B., & Mignatti, P. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1659 · Cited by 860
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Molecular targeted therapy of glioblastoma
Le Rhun, E., Preusser, M., Roth, P., Reardon, D. A., van den Bent, M., Wen, P., Reifenberger, G., & Weller, M. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101896 · Cited by 688
Vascular endothelial growth factor and its receptors
Klagsbrun, M., & A. D'Amore, P. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00027-5 · Cited by 682
Differential Roles of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Angiogenesis
Shibuya, M. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.5.469 · Cited by 623
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Fischer, C., Mazzone, M., Jonckx, B., & Carmeliet, P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2524 · Cited by 568
Dankbar, B., Padró, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R. M., Serve, H., Berdel, W. E., & Kienast, J. (2000) · Blood · doi:10.1182/blood.v95.8.2630 · Cited by 566
Holland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3675 · Cited by 556
Wick, W., Puduvalli, V. K., Chamberlain, M. C., van den Bent, M. J., Carpentier, A. F., Cher, L. M., Mason, W., Weller, M., Hong, S., Musib, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2595 · Cited by 525
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510
Stratmann, A., Risau, W., & Plate, K. H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65733-1 · Cited by 485
Self-citationBrown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., & Dvorak, H. F. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_10 · Cited by 472
Fiedler, W., Graeven, U., Ergün, S., Verago, S., Kilic, N., Stockschläder, M., & Hossfeld, D. K. (1997) · Blood · doi:10.1182/blood.v89.6.1870 · Cited by 437
van der Zee, R., Murohara, T., Luo, Z., Zollmann, F., Passeri, J., Lekutat, C., & Isner, J. M. (1997) · Circulation · doi:10.1161/01.cir.95.4.1030 · Cited by 403
Redefining the Target: Chemotherapeutics as Antiangiogenics
Miller, K. D., Sweeney, C. J., & Sledge, G. W. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1195 · Cited by 395
Flamme, I., Fröhlich, T., von Reutern, M., Kappel, A., Damert, A., & Risau, W. (1997) · Mechanisms of Development · doi:10.1016/s0925-4773(97)00674-6 · Cited by 366
Self-citationAngiogenesis in Gliomas: Biology and Molecular Pathophysiology
Fischer, I., Gagner, J., Law, M., Newcomb, E. W., & Zagzag, D. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00115.x · Cited by 350
Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B., & Isner, J. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118437 · Cited by 342
Angiogenesis in malignant gliomas
Plate, K. H., & Risau, W. (1995) · Glia · doi:10.1002/glia.440150313 · Cited by 337
Self-citationBrat, D. J., & Van Meir, E. G. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700070 · Cited by 330
Blood–brain barrier breakdown in septic encephalopathy and brain tumours*
Davies, D. C. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00065.x · Cited by 309
Molecular mechanisms of brain tumor edema
Papadopoulos, M. C., Saadoun, S., Binder, D. K., Manley, G. T., Krishna, S., & Verkman, A. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.044 · Cited by 308
Witte, L., Hicklin, D. J., Zhu, Z., Pytowski, B., Kotanides, H., Rockwell, P., & Böhlen, P. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006094117427 · Cited by 307
VEGF and flt: Expression Time Kinetics in Rat Brain Infarct
Kovács, Z., Ikezaki, K., Samoto, K., Inamura, T., & Fukui, M. (1996) · Stroke · doi:10.1161/01.str.27.10.1865 · Cited by 277
Giraudo, E., Primo, L., Audero, E., Gerber, H.-P., Koolwijk, P., Soker, S., Klagsbrun, M., Ferrara, N., & Bussolino, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.22128 · Cited by 272
Horowitz, J. R., Rivard, A., van der Zee, R., Hariawala, M., Sheriff, D. D., Esakof, D. D., Chaudhry, G. M., Symes, J. F., & Isner, J. M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2793 · Cited by 266
Heiss, J. D., Papavassiliou, E., Merrill, M. J., Nieman, L., Knightly, J. J., Walbridge, S., Edwards, N. A., & Oldfield, E. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118927 · Cited by 256
Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by Hypoxia
Waltenberger, J., Mayr, U., Pentz, S., & Hombach, V. (1996) · Circulation · doi:10.1161/01.cir.94.7.1647 · Cited by 253
Rajendran, J. G., Wilson, D. C., Conrad, E. U., Peterson, L. M., Bruckner, J. D., Rasey, J. S., Chin, L. K., Hofstrand, P. D., Grierson, J. R., Eary, J. F., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1096-7 · Cited by 252
Integrating genetic and gene expression evidence into genome-wide association analysis of gene sets
Xiong, Q., Ancona, N., Hauser, E. R., Mukherjee, S., & Furey, T. S. (2012) · Genome Research · doi:10.1101/gr.124370.111 · Cited by 103
Chiarotto, J. A., & Hill, R. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690555 · Cited by 46
Metadata
- Authors
- Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D., & Risau, W.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1994-11-15
- Volume
- 59
- Issue
- 4
- Pages
- 520-529
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2053375897
- Cited by
- 463
- References
- 23
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.